GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » ROA %

ViaDerma (ViaDerma) ROA % : 8.42% (As of Jun. 2012)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. ViaDerma's annualized Net Income for the quarter that ended in Jun. 2012 was $3.82 Mil. ViaDerma's average Total Assets over the quarter that ended in Jun. 2012 was $45.38 Mil. Therefore, ViaDerma's annualized ROA % for the quarter that ended in Jun. 2012 was 8.42%.

The historical rank and industry rank for ViaDerma's ROA % or its related term are showing as below:

VDRM's ROA % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.615
* Ranked among companies with meaningful ROA % only.

ViaDerma ROA % Historical Data

The historical data trend for ViaDerma's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma ROA % Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
ROA %
-1,566.67 60.96 15.89 13.63 6.79

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.80 4.05 4.99 3.66 8.42

Competitive Comparison of ViaDerma's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViaDerma's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's ROA % distribution charts can be found below:

* The bar in red indicates where ViaDerma's ROA % falls into.



ViaDerma ROA % Calculation

ViaDerma's annualized ROA % for the fiscal year that ended in Dec. 2011 is calculated as:

ROA %=Net Income (A: Dec. 2011 )/( (Total Assets (A: Dec. 2010 )+Total Assets (A: Dec. 2011 ))/ count )
=2.673/( (36.074+42.645)/ 2 )
=2.673/39.3595
=6.79 %

ViaDerma's annualized ROA % for the quarter that ended in Jun. 2012 is calculated as:

ROA %=Net Income (Q: Jun. 2012 )/( (Total Assets (Q: Mar. 2012 )+Total Assets (Q: Jun. 2012 ))/ count )
=3.82/( (44.93+45.832)/ 2 )
=3.82/45.381
=8.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2012) net income data. ROA % is displayed in the 30-year financial page.


ViaDerma  (OTCPK:VDRM) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2012 )
=Net Income/Total Assets
=3.82/45.381
=(Net Income / Revenue)*(Revenue / Total Assets)
=(3.82 / 23.268)*(23.268 / 45.381)
=Net Margin %*Asset Turnover
=16.42 %*0.5127
=8.42 %

Note: The Net Income data used here is four times the quarterly (Jun. 2012) net income data. The Revenue data used here is four times the quarterly (Jun. 2012) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


ViaDerma ROA % Related Terms

Thank you for viewing the detailed overview of ViaDerma's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.

ViaDerma (ViaDerma) Headlines

From GuruFocus

ViaDerma, Inc. Provides Updates on Current Business Activities

By Marketwired Marketwired 06-24-2021

ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development

By Stock market mentor Stock market mentor 01-12-2023

ViaDerma, Inc. Provides a Corporate Update

By GlobeNewswire GlobeNewswire 01-16-2020

ViaDerma Provides an Update to Shareholders via a Letter from the CEO

By GlobeNewswire GlobeNewswire 07-12-2018

ViaDerma, Inc. Provides a Corporate Update

By Marketwired Marketwired 06-23-2020